Fusion Pharmaceuticals Inc.: key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2023)
- $2.1M
- Net Income/Loss (FY2023)
- -$94.9M
- Total Assets (FY2023)
- $285.8M
- Total Equity (FY2023)
- $222.5M
- Cash Flows from Operating Activities (FY2023)
- -$81.8M
Source: Fusion Pharmaceuticals Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
